Peptides

Semaglutide plateau: why it happens and what the data show
In short: what is „plateau“ in weight loss with Semaglutide ? „Plateau“ means that the rate of loss visibly slows or stops for weeks, and sometimes months — even though habits, dose or activity have…
Retatrutide — how it works, what the data show and what the effects are
What is Retatrutide Retatrutide (Retatrutide) (CAS 2381089-83-2) is an experimental peptide agonist that activates triple GLP-1, GIP and glucagon receptors . It is being studied in clinical trials in…
🧬 Semaglutide – how the GLP-1 agonist works and what the studies show
What is Semaglutide in brief Semaglutide is a synthetic analogue of GLP‑1 (glucagon‑like peptide‑1) with an ~weekly half‑life, designed to bind to albumin and thus be administered once weekly in its…
Tirzepatide: Science, studies and safety data
Tirzepatide: a scientific review of weight-loss efficacy and a comparative analysis with Semaglutide Tirzepatide is the first-in-class dual GIP and GLP‑1 receptor agonist, developed for the treatment…
Semaglutide: Science, Results and Clinical Trials
What is semaglutide? Semaglutide is a GLP‑1 receptor agonist – a modified peptide that stimulates glucose‑dependent insulin secretion, suppresses glucagon, delays gastric emptying and reduces…